Skip to main
OPCH
OPCH logo

OPCH Stock Forecast & Price Target

OPCH Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 56%
Hold 22%
Sell 0%
Strong Sell 0%

Bulls say

Option Care Health Inc. demonstrated strong financial performance with gross profit reaching $269.0 million, reflecting an 8% year-over-year growth, surpassing estimates. The company's chronic therapy business also exhibited robust expansion, growing at over 10%. Furthermore, Option Care Health increased its 2025 revenue outlook to a range of $5.5 billion to $5.65 billion, representing a 12% year-over-year growth at the midpoint, alongside raised guidance for adjusted financial metrics.

Bears say

The financial outlook for Option Care Health Inc appears negative due to several key factors impacting its profitability and revenue stability. A significant concern is the reliance on a single largest customer, which contributed 14% of the company's 2023 revenue; losing this client could substantially harm overall revenue and profitability. Additionally, limitations on gross margin expansion stem from the faster growth of lower-margin chronic therapies compared to higher-margin acute therapies, which poses a challenge for future EBITDA margin improvement amid projected gross profit headwinds associated with the Stelara item.

OPCH has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 56% recommend Buy, 22% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Option Care Health (OPCH) Forecast

Analysts have given OPCH a Buy based on their latest research and market trends.

According to 9 analysts, OPCH has a Buy consensus rating as of Nov 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $35.22, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $35.22, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Option Care Health (OPCH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.